Fidia Pharma USA Inc
Alberto Luis Martinez is a seasoned professional sales representative with extensive experience in the pharmaceutical and healthcare industries. Currently with Fidia Pharma USA Inc since June 2018, Alberto promotes products including Hymovis, Triluron, and Hyalgan for osteoarthritis of the knee, and has successfully launched a new Orthobiologic Amnio injectable. Previous roles include senior sales positions at Ashfield, inVentiv Health Commercial, and Daiichi Sankyo, where Alberto consistently achieved top sales rankings, recognized for leadership qualities and strategic contributions to sales growth. A graduate of St. Thomas University with a Bachelor's Degree in Business/Corporate Communications, Alberto has continuously demonstrated strong performance across various medical sectors, contributing to significant sales achievements and client satisfaction.
This person is not in any offices
Fidia Pharma USA Inc
Fidia Pharma USA Inc is a wholly-owned subsidiary of the Italian pharmaceutical manufacturer Fidia Farmaceutici S.p.A., an established leader in the hyaluronic acid (HA) market segment. Fidia Pharma USA is focused on continually expanding Fidia’s position in the U.S. and Canadian market, while upholding the company's mission to provide consumers with innovative products that offer quality, safety and performance, establishing a sound strategic presence of Fidia in the US consistently with the Company's mission and strategy pillars. Drawing on the strengths of the parent company, Fidia Pharma USA product portfolio focuses primarily on therapeutic areas such as joint healthcare and tissue repair. Fidia Pharma USA Inc is headquartered in Parsippany, NJ.